Sign in

CIK 0001817241 · <br>Emerging growth company

Artiva Biotherapeutics, Inc.

Sign in to watch
Ticker
ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863614316
Phone
(858) 267-4467
Business address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,341,159
in 16 filings, $529K under 10b5-1 plans

Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aslan Fred −$1.8M Chief Executive Officer sold 14% of stake
  2. Horan Christopher −$230K Chief Tech Operations Officer sold 9% of stake
  3. Bush Jennifer −$186K COO, CLO, Compliance Officer sold 7% of stake
  4. Banerjee Subhashis −$128K Chief Medical Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-09 Miralles Gines Diego President & Head of R&D Grant or award +45,000 122,500
2026-09-09 Miralles Gines Diego President & Head of R&D Grant or award · Employee Stock Option (Right to Buy) +135,000 135,000
2026-09-09 Horan Christopher Chief Tech Operations Officer Grant or award +40,000 323,084
2026-09-09 Horan Christopher Chief Tech Operations Officer Grant or award · Employee Stock Option (Right to Buy) +120,000 120,000
2026-09-09 Bush Jennifer COO, CLO, Compliance Officer Grant or award +45,000 374,529
2026-09-09 Bush Jennifer COO, CLO, Compliance Officer Grant or award · Employee Stock Option (Right to Buy) +135,000 135,000
2026-09-09 Banerjee Subhashis Chief Medical Officer Grant or award +30,000 170,947
2026-09-09 Banerjee Subhashis Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +85,000 85,000
2026-09-08 Aslan Fred Chief Executive Officer Sale 10b5-1 −23,429 $10.92 $256K 1,449,765
2026-09-08 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 Stoppel Laura Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 Sorg Elaine K. Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 HOUGEN ELIZABETH L Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 DANIELS BRIAN Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 Baker Daniel G. Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-08 MOORE ALISON Director Grant or award · Director Stock Option (Right to Buy) +13,750 13,750
2026-09-03 Horan Christopher Chief Tech Operations Officer Sale −10,366 $11.16 $116K 283,084
2026-09-03 Bush Jennifer COO, CLO, Compliance Officer Sale −8,391 $11.16 $94K 329,529
2026-09-03 Banerjee Subhashis Chief Medical Officer Sale −1,100 $11.16 $12K 140,947
2026-09-03 Aslan Fred Chief Executive Officer Sale −61,888 $11.16 $690K 1,473,194

Page 2 of 11 · 203 trades